Gil Schwartzberg
2021
In 2021, Gil Schwartzberg earned a total compensation of $1.1M as Director at LIXTE BIOTECHNOLOGY HOLDINGS.
Compensation breakdown
| Option Awards | $1,037,830 |
|---|---|
| Other | $14,556 |
| Total | $1,052,386 |
Schwartzberg received $1M in option awards, accounting for 99% of the total pay in 2021.
Schwartzberg also received $14.6K in other compensation.
Rankings
In 2021, Gil Schwartzberg's compensation ranked 8,632nd out of 12,415 executives tracked by ExecPay. In other words, Schwartzberg earned more than 30.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,632 out of 12,415 | 31st |
Division Manufacturing | 3,829 out of 5,508 | 31st |
Major group Chemicals And Allied Products | 1,694 out of 2,378 | 29th |
Industry group Drugs | 1,507 out of 2,099 | 28th |
Industry Pharmaceutical Preparations | 1,123 out of 1,549 | 28th |
Source: SEC filing on November 4, 2024.
Schwartzberg's colleagues
We found five more compensation records of executives who worked with Gil Schwartzberg at LIXTE BIOTECHNOLOGY HOLDINGS in 2021.